We are live on ! Find out more
TTHI

TRANSITION THERAPEUTICS INC (CANADA)
TTHI

Delisted

TTHI was delisted on the 30th of August, 2016.

20 hedge funds and large institutions have $14.7M invested in TRANSITION THERAPEUTICS INC (CANADA) in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

8% more capital invested

Capital invested by funds: $13.6M → $14.7M (+$1.1M)

9% less funds holding

Funds holding: 2220 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
6
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change

TTHI Hedge Fund Activity: Q2 2016 in Review

20 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in TRANSITION THERAPEUTICS INC (CANADA) (TTHI) for Q2 2016, worth a combined $14.7M — up 8.1% from $13.6M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of TTHI and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 6 added.

The largest buyer was Kassirer Asset Management, opening a new position worth an estimated $43.4K. The largest seller was Alyeska Investment Group, cutting an estimated $220K.

  • 20 institutional investors held TRANSITION THERAPEUTICS INC (CANADA) (TTHI) as of Q2 2016, down from 22 in Q1 2016.
  • Funds reported $14.7M of TRANSITION THERAPEUTICS INC (CANADA) stock for Q2 2016, up 8.1% quarter-over-quarter.
  • 1 fund opened new TRANSITION THERAPEUTICS INC (CANADA) positions in Q2 2016 and 3 closed out, a net change of -2 holders.
  • The largest TRANSITION THERAPEUTICS INC (CANADA) buyer in Q2 2016 was Kassirer Asset Management, an estimated $43.4K added.
  • The largest TRANSITION THERAPEUTICS INC (CANADA) seller in Q2 2016 was Alyeska Investment Group, an estimated $220K sold.

Based on aggregated 13F filings for Q2 2016.